Vitreous Levels of Erythropoietin and Vascular Endothelial Growth Factor in Eyes with Retinopathy of Prematurity

Ophthalmology

Volumn 116, Issue 9, 2009, Pages 1599-1603

  Sato, Tatsuhiko ^a   Kusaka, Shunji ^a   Shimojo, Hiroshi ^a   Fujikado, Takashi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ERYTHROPOIETIN; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; CONGENITAL CATARACT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; VASCULARIZATION; VITRECTOMY; VITREOUS BODY;

ANTIBODIES, MONOCLONAL; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INJECTIONS; LASER COAGULATION; MALE; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY; VITREOUS BODY;

EID: 69249174238     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.12.023     Document Type: Article

References (22)

1. Terry T.L. Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects. Trans Am Ophthalmol Soc 40 (1942) 262-284
2. Mechoulam H., and Pierce E.A. Retinopathy of prematurity: molecular pathology and therapeutic strategies. Am J Pharmacogenomics 3 (2003) 261-277
3. Sonmez K., Drenser K.A., Capone Jr. A., and Trese M.T. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology 115 (2008) 1065-1070
4. Mintz-Hittner H.A., and Kuffel Jr. R.R. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28 (2008) 831-838
5. Kusaka S., Shima C., Wada K., et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 92 (2008) 1450-1455
6. Chen J., and Smith L.E. Retinopathy of prematurity. Angiogenesis 10 (2007) 133-140
7. Fisher J.W. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 228 (2003) 1-14
8. Ohlsson A., and Aher S.M. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 3 (2006) CD004863
9. Suk K.K., Dunbar J.A., Liu A., et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model. J AAPOS 12 (2008) 233-238
10. Watanabe D., Suzuma K., Matsui S., et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353 (2005) 782-792
11. Aiello L.P. Angiogenic pathways in diabetic retinopathy. N Engl J Med 353 (2005) 839-841
12. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity Revisited. Arch Ophthalmol 123 (2005) 991-999
13. Gimbel H.V., and DeBroff B.M. Posterior capsulorrhexis with optic capture: maintaining a clear visual axis after pediatric cataract surgery. J Cataract Refract Surg 20 (1994) 658-664
14. Becerra S.P., and Amaral J. Erythropoietin-an endogenous retinal survival factor. N Engl J Med 347 (2002) 1968-1970
15. Tsai J.C., Song B.J., Wu L., and Forbes M. Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma. J Glaucoma 16 (2007) 567-571
16. Chen J., and Smith L.E. A double-edged sword: erythropoietin eyed in retinopathy of prematurity. J AAPOS 12 (2008) 221-222
17. Chen J., Connor K.M., Aderman C.M., and Smith L.E. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118 (2008) 526-533
18. Martinez-Estrada O.M., Rodriguez-Millan E., Gonzalez-De Vicente E., et al. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18 (2003) 2538-2544
19. Bierer R., Peceny M.C., Hartenberger C.H., and Ohls R.K. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants [online report]. Pediatrics 118 (2006) e635-e640. http://pediatrics.aappublications.org/cgi/content/full/118/3/e635 Accessed November 13, 2008
20. Xenocostas A., Cheung W.K., Farrell F., et al. The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 61 (2005) 189-195
21. Patel S., Rowe M.J., Winters S.A., and Ohls R.K. Elevated erythropoietin mRNA and protein concentrations in the developing human eye. Pediatr Res 63 (2008) 394-397
22. Hernandez C., Fonollosa A., Garcia-Ramirez M., et al. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patient with diabetic macular edema. Diabetes Care 29 (2006) 2028-2033